Although survival rates for acute myeloid leukemia (AML) continue to improve, many long-term survivors face persistent physical limitations, high rates of comorbidities, and suboptimal lifestyle ...
Fraud and anti-money laundering (AML) capabilities have advanced significantly in recent years. Yet in many institutions the two functions still operate on separate data, systems and incentives, ...
Anthracycline and cytarabine chemotherapy has been the backbone of induction chemotherapy for AML for more than 50 years. Advances in our understanding of leukemia biology and the development of ...
Revumenib demonstrates significant efficacy in R/R AML with NPM1m, KMT2Ar, and NUP98r, showing high response rates and tolerability. The AUGMENT-101 study reports a 26% CR/CRh rate in NPM1-mutated AML ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results